SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

16 مايو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

11 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

22 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

16 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

03 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

20 ديسمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

09 نوفمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies London Healthcare Conference

02 نوفمبر 2021 08:30:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021

10 سبتمبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

01 سبتمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

11 أغسطس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study

13 يوليو 2021 16:08:26 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Receipt of Written Minutes from Type C Meeting with the FDA Regarding Development of FUROSCIX®

01 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

19 مايو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

12 مايو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

23 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present in Two Upcoming Investor Conferences

25 فبراير 2021 08:00:02 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA

23 فبراير 2021 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors

17 فبراير 2021 08:00:01 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

11 فبراير 2021 08:00:01 بحسب Nasdaq GlobeNewswire